Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  p38 MAPK inhibitor LY2228820 dimesylate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-2 of 2 for your search:
Start Over
A Multicenter Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors
Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: Over 18 and under 80
Sponsor: Other
Protocol IDs: OLYMPE / 2013-005084-29, NCT02322853
A Study of LY2228820 in Patients With Advanced Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 12284, I1D-MC-JIAD, NCT01393990
Start Over